CAUTION ADVISED USING COMBINATION KETOCONAZOLE AND PD-1 INHIBITORS

OBJECTIVE: Immune checkpoint inhibitors are approved to treat multiple cancers. We report life-threatening hepatic failure in 2 consecutive patients with Cushing syndrome that were treated with ketoconazole (KTZ) in combination with 2 different programmed cell death protein 1 (PD-1) inhibitors, Nivo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AACE Clin Case Rep
Main Authors: Yang, Yingying, Hecht, Joel R., Liu, Sandy Ting, Cohen, Melissa J., Hart, Steven D., Wang, Hanlin L., Heaney, Anthony P.
Formato: Artigo
Idioma:Inglês
Publicado: American Association of Clinical Endocrinologists 2020
Assuntos:
Case Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7511096/
https://ncbi.nlm.nih.gov/pubmed/32984529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2020-0100
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares